Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Westminster Group establishes new cyber and defence technology unit

(Sharecast News) - Managed services and security firm Westminster Group said on Monday that it has established a new cyber and defence technology division. Westminster noted that global conflict was now at the highest level since the Second World War, while cybercrime was also at an all-time high from individuals, organisations and state actors.

As a result, the AIM-listed group said it had chosen to establish its new cyber and defence technology unit, which will be focussed on providing governments and organisations with "a range of solutions" to meet the "growing challenges" of an "uncertain world".

Chief executive Peter Fowler said: "Whilst we already have a wide portfolio of security and non-aggressive defence solutions being delivered through our various operating companies, we believe establishing a division focussed on the growing threats from conflict and cyber-attack would be beneficial in establishing Westminster as a leader in this area.

"To those ends, we are already in discussions with potential partners and specialist manufacturers in the sector to provide additional products and solutions that we believe will lead to an exciting future expansion of our services."

As of 1000 BST, Westminster shares were down 2.08% at 2.35p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.